Science Explorer Back to mapMap

Most cited papers from Rinku General Medical Center

What are the most cited papers from Rinku General Medical Center?

The most cited paper from Rinku General Medical Center is "Association of Hypoadiponectinemia With Coronary Artery Disease in Men" (Masahiro Kumada, Shinji Kihara, Satoru Sumitsuji et al., 2003), with 1,431 citations. Next come "Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017" (828) and "Clinical Genetic Testing for Familial Hypercholesterolemia" (624).

Showing 50 of 61 papers. Every paper with more than 76 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Association of Hypoadiponectinemia With Coronary Artery Disease in Men Masahiro Kumada, Shinji Kihara, Satoru Sumitsuji et al. · Arteriosclerosis Thrombosis and Vascular Biology 2003 1,431
2 Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 Makoto Kinoshita et al. · Journal of Atherosclerosis and Thrombosis Open access 21 Aug 2018 828
3 Clinical Genetic Testing for Familial Hypercholesterolemia Amy Curry Sturm et al. · Journal of the American College of Cardiology Open access 30 Jul 2018 624
4 36th International Symposium on Intensive Care and Emergency Medicine R. M. Bateman et al. · Critical Care Open access2,440 authors Apr 2016 531
5 Phase III Study of Docetaxel Compared With Vinorelbine in Elderly Patients With Advanced Non–Small-Cell Lung Cancer: Results of the West Japan Thoracic Oncology Group Trial (WJTOG 9904) Shinzoh Kudoh, Koji Takeda, Kazuhiko Nakagawa et al. · Journal of Clinical Oncology Open access 28 Jul 2006 367
6 Effectiveness of BNCT for recurrent head and neck malignancies Itsuro Kato, Koji Ono, Yoshinori Sakurai et al. · Applied Radiation and Isotopes 8 Jul 2004 327
7 Phase II clinical study of photodynamic therapy using mono-l-aspartyl chlorin e6 and diode laser for early superficial squamous cell carcinoma of the lung Harubumi Kato, Kinya Furukawa, Masami Sato et al. · Lung Cancer 16 Jul 2003 325
8 Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022 Tomonori Okamura et al. · Journal of Atherosclerosis and Thrombosis Open access 18 Dec 2023 303
9 Pulmonary Nodules at Chest CT: Effect of Computer-aided Diagnosis on Radiologists’ Detection Performance Kazuo Awai, Kohei Murao, Akio Ozawa et al. · Radiology Feb 2004 274
10 Requirement of Caspase-3(-like) Protease-mediated Hydrogen Peroxide Production for Apoptosis Induced by Various Anticancer Drugs Siro Simizu, Minoru Takada, Kazuo Umezawa et al. · Journal of Biological Chemistry Open access Oct 1998 268
11 A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas Hideyuki Arita et al. · Acta Neuropathologica Communications Open access 8 Aug 2016 267
12 International Atherosclerosis Society guidance for implementing best practice in the care of familial hypercholesterolaemia Gerald F. Watts et al. · Nature Reviews Cardiology ReviewOpen access 15 Jun 2023 250
13 Effect of Contrast Material Injection Duration and Rate on Aortic Peak Time and Peak Enhancement at Dynamic CT Involving Injection Protocol with Dose Tailored to Patient Weight Kazuo Awai, Kumiko Hiraishi, Shinichi Hori · Radiology 2004 248
14 FGF-2 Stimulates Periodontal Regeneration Masahiro Kitamura et al. · Journal of Dental Research 8 Nov 2010 248
15 Variations in the FTO gene are associated with severe obesity in the Japanese Kikuko Hotta et al. · Journal of Human Genetics Open access 31 Mar 2008 246
16 Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or Older (EWTOPIA 75) Yasuyoshi Ouchi et al. · Circulation Open access 22 Aug 2019 227
17 Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease Tomonori Kimura, Kenji Hamase, Yurika Miyoshi et al. · Scientific Reports Open access 18 May 2016 224
18 Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial Shun Ishibashi, Shizuya Yamashita, Hidenori Arai et al. · Atherosclerosis Open access 26 Feb 2016 216
19 Periodontal Tissue Regeneration Using Fibroblast Growth Factor -2: Randomized Controlled Phase II Clinical Trial Masahiro Kitamura et al. · PLoS ONE Open access Jul 2008 205
20 Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease Koji Ohashi et al. · Journal of the American College of Cardiology Open access Apr 2004 203
21 Pemafibrate, a New Selective PPARα Modulator: Drug Concept and Its Clinical Applications for Dyslipidemia and Metabolic Diseases Shizuya Yamashita, Daisaku Masuda, Yūji Matsuzawa · Current Atherosclerosis Reports Open access 2020 190
22 Efficacy and safety of pemafibrate (K-877), a selective peroxisome proliferator-activated receptor α modulator, in patients with dyslipidemia: Results from a 24-week, randomized, double blind, active-controlled, phase 3 trial Shun Ishibashi, Hidenori Arai, Koutaro Yokote et al. · Journal of clinical lipidology Open access 28 Oct 2017 189
23 2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma Chantal A Lebbink, Thera P. Links, Agnieszka Czarniecka et al. · European Thyroid Journal Open access 13 Oct 2022 182
24 Aortic and Hepatic Enhancement and Tumor-to-Liver Contrast: Analysis of the Effect of Different Concentrations of Contrast Material at Multi–Detector Row Helical CT Kazuo Awai, Koichi Takada, Hiromitsu Onishi et al. · Radiology Sep 2002 164
25 Effects of Pemafibrate, a Novel Selective PPARα Modulator, on Lipid and Glucose Metabolism in Patients With Type 2 Diabetes and Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Eiichi Araki, Shizuya Yamashita, Hidenori Arai et al. · Diabetes Care 3 Jan 2018 163
26 Discontinuation of imatinib in Japanese patients with chronic myeloid leukemia Naoto Takahashi, Taiichi Kyo, Yasuhiro Maeda et al. · Haematologica Open access 16 Dec 2011 150
27 Postprandial Hyperlipidemia and Remnant Lipoproteins Daisaku Masuda, Shizuya Yamashita · Journal of Atherosclerosis and Thrombosis Open access 7 Nov 2016 149
28 Frequent and histological type-specific inactivation of 14-3-3σ in human lung cancers Hirotaka Osada, Yoshio Tatematsu, Yasushi Yatabe et al. · Oncogene 4 Apr 2002 147
29 Randomized Placebo-Controlled and Controlled Non-Inferiority Phase III Trials Comparing Trafermin, a Recombinant Human Fibroblast Growth Factor 2, and Enamel Matrix Derivative in Periodontal Regeneration in Intrabony Defects Masahiro Kitamura et al. · Journal of Bone and Mineral Research Open access 7 Nov 2015 147
30 Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care Gerald F. Watts, Samuel S. Gidding, Pedro Mata et al. · Nature Reviews Cardiology ReviewOpen access 23 Jan 2020 146
31 The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential Jean‐Charles Fruchart et al. · Cardiovascular Diabetology Open access 4 Jun 2019 145
32 Smaller introducer sheaths for REBOA may be associated with fewer complications William Arthur Teeter, Junichi Matsumoto, Koji Idoguchi et al. · The Journal of Trauma: Injury, Infection, and Critical Care 28 May 2016 143
33 Association between obesity and polymorphisms in SEC16B, TMEM18, GNPDA2, BDNF, FAIM2 and MC4R in a Japanese population Kikuko Hotta et al. · Journal of Human Genetics 23 Oct 2009 143
34 Role of disseminated intravascular coagulation in severe sepsis Satoshi Gando et al. · Thrombosis Research 26 Apr 2019 139
35 Efficacy and Safety of Pemafibrate Versus Fenofibrate in Patients with High Triglyceride and Low HDL Cholesterol Levels: A Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Journal of Atherosclerosis and Thrombosis Open access 6 Apr 2018 137
36 Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia Hidenori Arai, Shizuya Yamashita, Koutaro Yokote et al. · Atherosclerosis Open access 24 Mar 2017 127
37 Effects of clazosentan on cerebral vasospasm–related morbidity and all-cause mortality after aneurysmal subarachnoid hemorrhage: two randomized phase 3 trials in Japanese patients Hidenori Endo, Yasushi Hagihara, Naoto Kimura et al. · Journal of neurosurgery Open access 8 Apr 2022 124
38 Fewer REBOA complications with smaller devices and partial occlusion: evidence from a multicentre registry in Japan Yosuke Matsumura, Junichi Matsumoto, Hiroshi Kondo et al. · Emergency Medicine Journal 31 Aug 2017 123
39 Efficacy and Safety of 5-Day Oral Ensitrelvir for Patients With Mild to Moderate COVID-19 Hiroshi Yotsuyanagi, Norio Ohmagari, Yohei Doi et al. · JAMA Network Open Open access 9 Feb 2024 122
40 Serum exosomal miR‐638 is a prognostic marker of HCC via downregulation of VE‐cadherin and ZO‐1 of endothelial cells Yuki Yokota, Takehiro Noda, Yuichiro Okumura et al. · Cancer Science Open access 15 Jan 2021 113
41 Diagnosis and Management of Sitosterolemia 2021 Hayato Tada, Akihiro Nomura, Masatsune Ogura et al. · Journal of Atherosclerosis and Thrombosis Open access 27 Apr 2021 111
42 Reconstruction with an Osteochondral Autograft for Advanced Osteochondritis Dissecans of the Elbow Kozo Shimada, Takeshi Yoshida, Ken Nakata et al. · Clinical Orthopaedics and Related Research Jun 2005 111
43 Second nation-wide study of atherosclerosis in infants, children and young adults in Japan Masami Imakita, Chikao Yutani, Jack P. Strong et al. · Atherosclerosis Apr 2001 110
44 Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse Saiko Kurosawa, Tomohiko YAMAGUCHI, Shuich Miyawaki et al. · Haematologica Open access 15 Jul 2010 109
45 Thiazolidinedione derivative improves fat distribution and multiple risk factors in subjects with visceral fat accumulation—double-blind placebo-controlled trial Tadashi Nakamura, Tohru Funahashi, Shizuya Yamashita et al. · Diabetes Research and Clinical Practice Dec 2001 103
46 Guidelines for the Diagnosis and Treatment of Adult Familial Hypercholesterolemia 2022 Mariko Harada‐Shiba, Hidenori Arai, Hirotoshi Ohmura et al. · Journal of Atherosclerosis and Thrombosis Open access 20 Jan 2023 102
47 Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas Hideyuki Arita et al. · Scientific Reports Open access 31 Jul 2018 101
48 Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database Hajime Nagasu et al. · Diabetes Care Open access 30 Sep 2021 95
49 Guidelines for the Diagnosis and Treatment of Pediatric Familial Hypercholesterolemia 2022 Mariko Harada‐Shiba, Akira Ohtake, Daisuke Sugiyama et al. · Journal of Atherosclerosis and Thrombosis Open access 19 Jan 2023 93
50 Guidance for Pediatric Familial Hypercholesterolemia 2017 Mariko Harada‐Shiba, Takao Ohta, Akira Ohtake et al. · Journal of Atherosclerosis and Thrombosis Open access 5 Feb 2018 92

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.